Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Platelet storage pool deficiency refers to a group of conditions that are caused by problems with the platelet granules. Platelet granules are tiny storage sacs found within the platelets which release various substances to help stop bleeding. Platelet storage pool deficiencies occur when platelet granules are absent, reduced in number, or unable to empty their contents into the bloodstream. The signs and symptoms include frequent nosebleeds; abnormally heavy or prolonged menstruation ; easy bruising; recurrent anemia ; and abnormal bleeding after surgery, dental work or childbirth. Platelet storage pool deficiencies may be genetic or acquired (non-genetic). They can also be part of an inherited genetic syndrome such as Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, thrombocytopenia-absent radius (TAR) syndrome, and Wiskott-Aldrich syndrome. Treatment is symptomatic.
Features include: Abnormal bleeding tendency (abnormal bleeding), Acute leukemia, Prolonged bleeding time, and Myelodysplasia and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Abnormal bleeding tendency (abnormal bleeding), Prolonged bleeding time, Decreased mean platelet volume |
Biomarker and diagnostic research for platelet storage pool deficiency has been reported in the published literature.
No clinical trials have been registered for platelet storage pool deficiency.
72 publications have been identified in PubMed for platelet storage pool deficiency. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (33%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 24 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 9:04 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
24 |
33% |
Research summaries | 10 | 14% |
Testing and diagnosis research | 8 | 11% |
Disease patterns and progression | 6 | 8% |
Ghatge M (2026). [PMID: 41197806](https://pubmed.ncbi.nlm.nih.gov/41197806/). *J Thromb Haemost*. [Basic Science / Preclinical]
Giulianelli G (2026). [PMID: 42125657](https://pubmed.ncbi.nlm.nih.gov/42125657/). *Front Immunol*. [Case Report / Case Series]
Arif M (2026). [PMID: 40720784](https://pubmed.ncbi.nlm.nih.gov/40720784/). *Am J Respir Cell Mol Biol*. [Diagnostic / Biomarker]
Chen Y (2026). [PMID: 41878811](https://pubmed.ncbi.nlm.nih.gov/41878811/). *Circ Res*. [Basic Science / Preclinical]
Díaz-Ajenjo L (2026). [PMID: 41138802](https://pubmed.ncbi.nlm.nih.gov/41138802/). *J Thromb Haemost*. [Case Report / Case Series]
Zaninetti C (2026). [PMID: 41791656](https://pubmed.ncbi.nlm.nih.gov/41791656/). *J Thromb Haemost*. [Review / Meta-Analysis]
Li X (2026). [PMID: 41953037](https://pubmed.ncbi.nlm.nih.gov/41953037/). *Front Immunol*. [Case Report / Case Series]
Calabresi V (2026). [PMID: 41940244](https://pubmed.ncbi.nlm.nih.gov/41940244/). *Int Med Case Rep J*. [Case Report / Case Series]
Zuo MXG (2026). [PMID: 42150436](https://pubmed.ncbi.nlm.nih.gov/42150436/). *Mol Genet Metab*. [Epidemiology / Natural History]
Luquero A (2026). [PMID: 41042971](https://pubmed.ncbi.nlm.nih.gov/41042971/). *Eur Heart J*. [Basic Science / Preclinical]